Literature DB >> 10362041

Variability of aerosol delivery via spacer devices in young asthmatic children in daily life.

H M Janssens1, S G Devadason, W C Hop, P N LeSouëf, J C De Jongste, H A Tiddens.   

Abstract

Pressurized metered dose inhalers (pMDI) are widely used together with spacers for the treatment of asthma in children. However, the variability of daily medication dose for pMDI/spacer combinations is not known. Electrostatic charge is a potential source of dose variability. Metal spacers have no static charge. This study assessed and compared within-subject variability of aerosol delivery of metal and plastic spacers. This was a randomized, crossover study in children with stable asthma aged 1-4 (group I, n=17) and 5-8 (group II, n=16) yrs. In both groups the amount of drug delivered to the mouth by a metal spacer (Nebuchamber) and one of two plastic (polycarbonate) spacers, i.e. Babyhaler in group I and Volumatic in group II was measured. The metal and plastic spacers were tested at home in a randomized order for 7 days each, using budesonide (200 microg b.i.d.). Aerosol was collected on a filter positioned between spacer and facemask or mouth. Budesonide on the filter was assessed by high performance liquid chromatography. The mean filter dose for each child (mean+/-SD) during the 7 days was expressed as a percentage of the nominal dose. Within-subject variability was expressed as coefficient of variation (CV). Mean filter dose in group I was 41.7+/-10.1% for Nebuchamber and 26.0+/-4.0% for Babyhaler (p<0.001). Mean filter dose in group II was 50.2+/-9.2% for Nebuchamber and 19.4+/-7.2% for Volumatic (p<0.001). Mean CV in group I was 34% for Nebuchamber and 37% for Babyhaler (p=0.44). Mean CV in group II was 23% for Nebuchamber and 34% for Volumatic (p=0.003). There was substantial within-subject dose variability in aerosol delivery in children using a pMDI/spacer at home. This variability was lower for the metal than for the plastic spacer in children 5-8 yrs of age. The dose delivered to the mouth was about two-fold higher for the metal than the plastic spacer independent of age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362041     DOI: 10.1034/j.1399-3003.1999.13d15.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Funhaler spacer: improving adherence without compromising delivery.

Authors:  P M Watt; B Clements; S G Devadason; G M Chaney
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.

Authors:  Hugh D C Smyth; Vance P Beck; Dennis Williams; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2004-02-10       Impact factor: 3.246

3.  Inhalation devices.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 4.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Incentive device improves spacer technique but not clinical outcome in preschool children with asthma.

Authors:  André Schultz; Peter D Sly; Guicheng Zhang; André Venter; Peter N Le Souëf; Sunalene G Devadason
Journal:  J Paediatr Child Health       Date:  2011-11-01       Impact factor: 1.954

6.  Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!

Authors:  I Amirav; I Balanov; M Gorenberg; D Groshar; A S Luder
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

7.  Controller Inhalers: Overview of Devices, Instructions for Use, Errors, and Interventions to Improve Technique.

Authors:  Patrick K Gleeson; Scott Feldman; Andrea J Apter
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-12

8.  Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats.

Authors:  Hilliard L Kutscher; Piyun Chao; Manjeet Deshmukh; Yashveer Singh; Peidi Hu; Laurie B Joseph; David C Reimer; Stanley Stein; Debra L Laskin; Patrick J Sinko
Journal:  J Control Release       Date:  2010-01-05       Impact factor: 9.776

Review 9.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma.

Authors:  Alessandra Scaparrotta; Sabrina Di Pillo; Marina Attanasi; Daniele Rapino; Anna Cingolani; Nicola Pietro Consilvio; Marcello Verini; Francesco Chiarelli
Journal:  Multidiscip Respir Med       Date:  2012-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.